Model
Edge
BioCryst Pharmaceuticals Inc
0001760020
Filing Type
4
Filing Date
6/2/2024
Updated
6/3/24, 2:33 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership